Axovia, an innovative gene therapy company developing disease-transformative medicines for ciliopathies, is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by Deerfield Management and UCL Technology Fund. 

Read more

AlbionVC leads a £14m Series A investment into Solidatus, next generation data management platform, alongside HSBC Ventures and Citi.  

Read more

UCL Technology Fund portfolio company Quell Therapeutics, a biotechnology firm developing engineered T regulatory cell therapies, expands Series A financing to $84 Million. 

Read more

AlbionVC portfolio company Limitless, announces $10m Series B and adds Genesys as a new investor and technology partner to continue US expansion. 

Read more

UCL Technology Fund is delighted to announce that Leigh Brody, PhD and Dominik Leisi have joined the fund’s life sciences investment team.

Read more

Nadine Torbey, investor at AlbionVC discusses lessons learnt from working with early stage startups with the Silicon Republic. 

Read more

Phasecraft, a UCL Technology Fund portfolio company is taking quantum theory from research to reality, faster. Today it announces the largest seed funding round for a UK quantum computing company from a syndicate of new and existing investors.

Read more

DYSIS Medical announces reimbursement rates of $54.4 for computer-aided mapping of the cervix that will help increase patient access to DYSIS cervical mapping technology. 

Read more